The 10-year clinical outcomes of reduced-intensity allogeneic stem cell transplantation for patients with advanced-stage mycosis fungoides and Sezary syndrome

被引:0
|
作者
Ziaj, S. [1 ]
Morris, S. [1 ]
Child, F. [1 ]
Wain, M. [1 ]
Mitchell, T. [1 ]
Kanfer, E. [2 ]
Whittaker, S. [1 ]
机构
[1] St Johns Inst Dermatol, London, England
[2] Hammersmith Hosp, Dept Haematol, London, England
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
O06
引用
下载
收藏
页码:5 / 6
页数:2
相关论文
共 50 条
  • [21] Allogeneic hematopoietic stem cell transplantation for refractory mycosis fungoides (MF) and Sezary syndrome (SS)
    Atilla, Erden
    Atilla, Pinar Ataca
    Bozdag, Sinem Civriz
    Yuksel, Meltem Kurt
    Toprak, Selami Kocak
    Topcuoglu, Pervin
    Akay, Bengu Nisa
    Sanli, Hatice
    Gurman, Gunhan
    Ozcan, Muhit
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 106 (03) : 426 - 430
  • [22] Evidence of graft-versus-leukaemia following allogeneic haematopoietic stem cell transplantation in patients with advanced mycosis fungoides and Sezary syndrome
    Onida, F.
    Saporiti, G.
    Berti, E.
    Della Volpe, A.
    Annaloro, C.
    Tagliaferri, E.
    Vezzoli, P.
    Usardi, P.
    Deliliers, G. Lambertenghi
    BONE MARROW TRANSPLANTATION, 2008, 41 : S173 - S174
  • [23] Long term outcomes of nonmyeloablative allogeneic stem cell transplantation with TSEB TLI and ATG for Mycosis Fungoides and Sezary Syndrome
    Morris, S. L.
    Thomas, B. R.
    Palanicawandar, R.
    Whittaker, S.
    Child, F.
    Wain, M.
    Sim, V.
    Szydlo, R.
    Mangar, S.
    Olavarria, E.
    Cerrada, S. Lozano
    Muzamil, A.
    Kanfer, E.
    BONE MARROW TRANSPLANTATION, 2024, 59 (06) : 874 - 879
  • [24] Treatment of advanced mycosis fungoides by allogeneic stem cell transplantation with reduced intensity conditioning 2 regimen.
    Soligo, D
    Ibatici, A
    Berti, E
    Morandi, P
    Longhi, E
    Robbiolo, L
    Annaloro, C
    Della Volpe, A
    Grifoni, F
    Deliliers, GL
    BLOOD, 2002, 100 (11) : 457B - 457B
  • [25] Outpatient allogeneic hematopoietic cell transplant following alemtuzumab based reduced intensity conditioning in patients with advanced mycosis fungoides/Sezary syndrome.
    Purev, Enkhtsetseg
    Srinivasan, Ramaprasad
    Aue, George
    Stroncek, Dave
    Khuu, Hahn
    Ramos, Caltalina
    Cook, Lisa
    Cho, Elena
    Schmitt, Monica
    Childs, Richard W.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [26] Allogeneic Hematopoietic Cell Transplantation in Advanced Phase Mycosis Fungoides and Sezary Syndrome: A Retrospective Analysis of 57 Consecutive Patients
    Cavallaro, Francesca
    Versino, Francesco
    Serpenti, Fabio
    Iacobelli, Simona
    Violetti, Silvia Alberti
    Saporiti, Giorgia
    Goldaniga, Maria
    Galassi, Giulia
    Bagnoli, Filippo
    Rampi, Nicolo'
    Barbullushi, Kordelia
    Bosi, Alessandro
    Cassanello, Giulio
    Simontacchi, Gabriele
    Schiavone, Concetta
    Baldini, Luca
    Berti, Emilio
    Onida, Francesco
    BLOOD, 2022, 140 : 7721 - 7722
  • [27] Total Skin Electron Beam radiation therapy and allogeneic haematopoietic stem cell transplantation in advanced mycosis fungoides and Sezary syndrome
    Hosing, C.
    Saliba, R.
    Singh, L.
    Popat, U.
    Qazilbash, M.
    Anderlini, P.
    Nieto, Y.
    Alousi, A.
    Frazier, E.
    Dabaja, B.
    Champlin, R.
    Duvic, M.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S85 - S86
  • [28] Allogeneic hematopoietic stem cell transplantation for the treatment of patients with refractory mycosis fungoides/Sezary syndrome: a single center experience
    Papadavid, E.
    Pappa, V.
    Nikolaou, V.
    Hliakis, T.
    Gkirkas, K.
    Stamouli, M.
    Karagiannidi, A.
    Thomopoulos, T.
    Theodoropoulos, K.
    Tsirigotis, P.
    EUROPEAN JOURNAL OF CANCER, 2019, 119 : S34 - S34
  • [29] Allogeneic haemopoietic stem cell transplantation with reduced-intensity conditioning in patients with myelodysplastic syndrome
    Rudnitskaya, Y. V.
    Morozova, E.
    Zalyalov, Yu.
    Kazantsev, I.
    Afanasyev, B.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S406 - S407
  • [30] Durable Remission of Refractory and Advanced Stage Mycosis Fungoides/Sezary Syndrome (MF/SS) Utilizing an " Outpatient" Alemtuzumab and Fludarabine- Based Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT)
    Phuong Vo
    Srinivasan, Ramaprasad
    Purev, Enkhtsetseg
    McDuffee, Emily
    Cook, Lisa
    Worthy, Tatyana
    Hawks, Geri
    Patricia, Prince
    Shalabi, Reem
    Wells, Brian
    Reger, Robert
    Khuu, Hanh
    Stroncek, David
    Tian, Xin
    Geller, Nancy
    Aue, Georg
    Childs, Richard
    BLOOD, 2017, 130